PTGS2 and B-cell non-Hodgkin lymphoma: (2023) demonstrated a consistent correlation between PTGS2 upregulation and chromosome 17p deletions in human B-cell lymphomas, linking arachidonate metabolism as a new susceptibility factor for lymphoma (60).